October 13/2015 EuropeSmall Steps Towards Big Pricing Changes Pharm Exec’s Brussells correspondent Reflector outlines the current measures European countries are working or collaborating on to achieve a better understanding of pricing issues .../ Read more / |
||||||||||
|
| ||||||||||
| Emerging Markets What Makes A Good Patient Advocacy Strategy for Russia? Though advocacy communications is now recognized in established markets, there is no clear-cut path to success in creating an advocacy strategy. In regions such as Russia and CIS, advocacy strategies become even more complex due to the political, cultural and regulatory differences. Nick Hicks looks at ways of moving forward .../ Read more / |
||||||||||
| Technology Tablet Innovation: Sizing Up the Value A representative survey of Germans and Americans has revealed that solid oral dosage forms like tablets and capsules are far from optimal in many cases. In fact, 50% of people have problems swallowing medication in this form, resulting in many failing to adhere to their dosing regimen. This represents a big opportunity for pharma, writes Thomas Hein .../ Read more / |
||||||||||
| Social Media Tweets & Drugs & Rock n' Roll: The Power of the Shkreli Shockwaves Peter Houston was surprised to find himself discussing Turing Pharmaceutical’s Daraprim in the offices of ClassicRock magazine. What’s even more surprising was impact the price hike on the toxoplasmosis treatment was having on a punk record label .../ Read more / |
||||||||||
industry update
|
 |
 |
 |
 |
 |